Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Keyser

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Annals of the Rheumatic Diseases|May 27, 1999
Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritidesC Vincent, F de Keyser, C Masson-Bessière, et al.
Clinical Chemistry|February 1, 1990
"Microgel diffusion blotting" for sensitive detection of antibodies to extractable nuclear antigensF De Keyser, G Verbruggen, E M Veys, et al.
Clinical Rheumatology|July 1, 1996
Polyarteritis nodosa and the antiphospholipid syndromeR Schoonjans, B Van Vlem, S Weyers, et al.
Annals of the Rheumatic Diseases|June 2, 2000
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot studyF Van den Bosch, E Kruithof, D Baeten, et al.
The Journal of Rheumatology|December 29, 2000
Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA associationK de Vlam, H Mielants, C Cuvelier, et al.
Acta Clinica Belgica|January 1, 1990
Pulmonary metastases of a tibia adamantinoma. Case report and review of the literatureF De Keyser, J Vansteenkiste, P Van Den Brande, et al.
Clinical and Experimental Rheumatology|February 13, 2010
Validation of a new screening strategy for anti-extractable nuclear antigen antibodiesJ T Van Praet, B Vander Cruyssen, C Bonroy, et al.
Annals of the Rheumatic Diseases|March 14, 2002
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alphaF Van den Bosch, D Baeten, E Kruithof, et al.
Clinical Rheumatology|January 19, 2000
Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patientsD Baeten, F Van den Bosch, D Elewaut, et al.
Annals of the Rheumatic Diseases|September 25, 2004
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathyE Kruithof, D Baeten, F Van den Bosch, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Annals of the Rheumatic Diseases|May 27, 1999
Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritidesC Vincent, F de Keyser, C Masson-Bessière, et al.
Clinical Chemistry|February 1, 1990
"Microgel diffusion blotting" for sensitive detection of antibodies to extractable nuclear antigensF De Keyser, G Verbruggen, E M Veys, et al.
Clinical Rheumatology|July 1, 1996
Polyarteritis nodosa and the antiphospholipid syndromeR Schoonjans, B Van Vlem, S Weyers, et al.
Annals of the Rheumatic Diseases|June 2, 2000
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot studyF Van den Bosch, E Kruithof, D Baeten, et al.
The Journal of Rheumatology|December 29, 2000
Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA associationK de Vlam, H Mielants, C Cuvelier, et al.
Acta Clinica Belgica|January 1, 1990
Pulmonary metastases of a tibia adamantinoma. Case report and review of the literatureF De Keyser, J Vansteenkiste, P Van Den Brande, et al.
Clinical and Experimental Rheumatology|February 13, 2010
Validation of a new screening strategy for anti-extractable nuclear antigen antibodiesJ T Van Praet, B Vander Cruyssen, C Bonroy, et al.
Annals of the Rheumatic Diseases|March 14, 2002
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alphaF Van den Bosch, D Baeten, E Kruithof, et al.
Clinical Rheumatology|January 19, 2000
Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patientsD Baeten, F Van den Bosch, D Elewaut, et al.
Annals of the Rheumatic Diseases|September 25, 2004
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathyE Kruithof, D Baeten, F Van den Bosch, et al.
Pageof 14